CA2280416A1 - Remotely operable stent - Google Patents
Remotely operable stent Download PDFInfo
- Publication number
- CA2280416A1 CA2280416A1 CA002280416A CA2280416A CA2280416A1 CA 2280416 A1 CA2280416 A1 CA 2280416A1 CA 002280416 A CA002280416 A CA 002280416A CA 2280416 A CA2280416 A CA 2280416A CA 2280416 A1 CA2280416 A1 CA 2280416A1
- Authority
- CA
- Canada
- Prior art keywords
- stmt
- stent
- expansion
- actuators
- remotely
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/92—Stents in the form of a rolled-up sheet expanding after insertion into the vessel, e.g. with a spiral shape in cross-section
Abstract
A remotely operable stent is disclosed which is radially expandable and contractable along the longitudinal length of the stent. Once the stent is positioned within a body lumen requiring radial support, an actuator and expansion/contraction element increase the radial dimension of the stent along the stent's longitudinal length to provide such support. The stent is remotely operable in vivo using a remote activation system such that the radial dimension of the stent can be changed without the need to re-enter the body lumen.
Description
Attorney Docket: 0008.P.US
REMOTELY OPERABLE STENT
This application is a continuation-in-part of U. S. application Serial No.
08/854,927, filed May 13, 1997, now abandoned.
Field of the Invention The present invention relates to medical stems and more specifically to a stent that is expandable and contractable via remote means after insertion in vivo.
Background of the Invention In many clinical situations, a lumen in a human or animal body, such as a blood vessel or a urinary tract, can require internal support to ensure proper fluid flow. Support for a lumen can be provided by implantation of a stmt in the lumen, which can maintain the radial integrity of the lumen.
A stmt is typically a tubular metallic or polymeric body, which is carried on a dilatation catheter to a specific vascular location. The implantation of a stmt to maintain patency of a body lumen is well known in the art. In one cardiovascular application. a stmt is mounted on a balloon catheter and positioned at the appropriate site within an artery. The balloon is dilated to expand the stent against the vascular wall.
The balloon is thereafter deflated and removed, leaving the expanded stmt in place in the artery. Due to the structural integrity of the stmt, the arterial wall is supported by the stmt and prevented from recollapsing. An example of this method is described in U.S. Patent No.
5,292,321 which is herein incorporated by reference. The stmt may also be expandable via thermal energy through the use of electrical activation or radio-frequency electromagnetic irradiation, as described in U.S. Patent No. 5,562,641.
Several difficulties are associated with the positioning and use of the above-identified stems. For example, it is difficult to simultaneously maintain the radial rigidity and the longitudinal flexibility of the stent to facilitate proper stent delivery. Additionally, the rapid expansion of the stmt by such methods can injure the lumen to be protected, often leading to restenosis in the vessel lumen. Ideally, a stent would be expanded slowly over a prolonged period of time to reduce the likelihood of such injury and resulting restenosis.
Furthermore, it has been discovered that over time the movement, activity and changing medical condition of a patient can adversely affect stmt operation and/or dictate that a previously expanded stmt be further expanded to continue and/or augment the beneficial support provided by the stmt. Currently used stems are not capable of prolonged expansion since they are not expandable in vivo, after removal of the positioning catheter; similarly, stmt expansion after removal of the positioning catheter cannot be accomplished without re-entry into the lumen.
Accordingly, there remains a need in the art for a stmt that can be remotely expanded or contracted in vivo over a prolonged period of time.
Summary of the Invention
REMOTELY OPERABLE STENT
This application is a continuation-in-part of U. S. application Serial No.
08/854,927, filed May 13, 1997, now abandoned.
Field of the Invention The present invention relates to medical stems and more specifically to a stent that is expandable and contractable via remote means after insertion in vivo.
Background of the Invention In many clinical situations, a lumen in a human or animal body, such as a blood vessel or a urinary tract, can require internal support to ensure proper fluid flow. Support for a lumen can be provided by implantation of a stmt in the lumen, which can maintain the radial integrity of the lumen.
A stmt is typically a tubular metallic or polymeric body, which is carried on a dilatation catheter to a specific vascular location. The implantation of a stmt to maintain patency of a body lumen is well known in the art. In one cardiovascular application. a stmt is mounted on a balloon catheter and positioned at the appropriate site within an artery. The balloon is dilated to expand the stent against the vascular wall.
The balloon is thereafter deflated and removed, leaving the expanded stmt in place in the artery. Due to the structural integrity of the stmt, the arterial wall is supported by the stmt and prevented from recollapsing. An example of this method is described in U.S. Patent No.
5,292,321 which is herein incorporated by reference. The stmt may also be expandable via thermal energy through the use of electrical activation or radio-frequency electromagnetic irradiation, as described in U.S. Patent No. 5,562,641.
Several difficulties are associated with the positioning and use of the above-identified stems. For example, it is difficult to simultaneously maintain the radial rigidity and the longitudinal flexibility of the stent to facilitate proper stent delivery. Additionally, the rapid expansion of the stmt by such methods can injure the lumen to be protected, often leading to restenosis in the vessel lumen. Ideally, a stent would be expanded slowly over a prolonged period of time to reduce the likelihood of such injury and resulting restenosis.
Furthermore, it has been discovered that over time the movement, activity and changing medical condition of a patient can adversely affect stmt operation and/or dictate that a previously expanded stmt be further expanded to continue and/or augment the beneficial support provided by the stmt. Currently used stems are not capable of prolonged expansion since they are not expandable in vivo, after removal of the positioning catheter; similarly, stmt expansion after removal of the positioning catheter cannot be accomplished without re-entry into the lumen.
Accordingly, there remains a need in the art for a stmt that can be remotely expanded or contracted in vivo over a prolonged period of time.
Summary of the Invention
2 0 The present invention is directed towards a stent that is remotely expandable or contractable in vivo over a prolonged period of time following stmt implantation.
The stmt of the present invention comprises a radially cylindrical body portion.
Located at one or more locations along its longitudinal length is one or more actuators drivingly associated with one or more expansion/contraction elements that serve to expand 2 5 or contract the stmt's diameter. In a preferred embodiment, the stmt is manufactured and sized such that in a completely relaxed state (i.e., when no radial pressure is exerted on the main body of the stmt) the stmt is at its largest radial dimension. When the one or more expansion/contraction elements are activated by means of one or more signals to the one or more actuators, the main body is reduced/increased in radial dimension in direct proportion to the amount of pressure exerted by the activation of the expansion/contraction elements.
In another embodiment of the present invention, the stmt is manufactured and sized such that in a completely relaxed state the stmt exhibits its smallest radial dimension.
In this embodiment the one or more expansion/contraction elements apply radial pressure from within the main portion of the stmt. When the expansion/contraction elements are 1 o actuated by means of one or more signals received by the one or more actuators, the main body is increased/reduced in radial dimension in direct proportion to the amount of pressure exerted by the activation of the expansion/contraction elements.
In both of the above-identified embodiments, the one or more expansion/contraction elements are remotely operable by the activation of one or more actuators by any one of a number of remote means such as electromagnetic radiation, including radio frequency (RF) energy and infrared remote activation and control systems.
In use, the remotely operable stmt of the present invention is prepared for insertion into the body lumen requiring physical radial support by adjusting the size of the main body of the stmt. If the embodiment includes the stmt manufactured and sized to have its 2 0 largest radial dimension when in a completely relaxed state, this is accomplished by actuating the actuators) which in turn drive, or activate the expansion/contraction elements to apply radial pressure to the external surface of the main body of the stmt, thus reducing the radial dimension of the stmt. This reduction is continued until the radial dimension of the stmt is small enough to allow the stent to pass through the path of the 2 5 body lumen and to be positioned appropriately, at which point the activation signals are terminated. In the second embodiment, when the stmt is manufactured and sized to have its smallest radial dimension when in a completely relaxed state, the natural state of the stmt is appropriate for insertion and thus actuation of the one or more actuators drivingly associated with the expansion/contraction is not required.
Once positioned within the body lumen, the main body of the stmt is expanded or contracted by transmitting the activation signals) to the actuators) which control the expansion/contraction elements to remove or add radial pressure and thereby to provide more or less radial support. The main body of the stmt is expanded to its initial configuration (i.e., either slightly expanded, or alternatively, expanded to its full radial dimension), depending upon the needs of the patient, the condition of the body lumen requiring support and other factors.
Once the remotely operable stent of the present invention is in the initial configuration, the insertion procedure is completed. Subsequently, unlimited adjustments to the stmt's initial configuration can be accomplished via remote means, without additional invasive means. Accordingly, the stmt can be incrementally expanded over a prolonged period of time to reduce the chance of injury or rupture to the lumen to be supported. Additionally, as the activity and/or condition of the patient warrants, adjustments to the stent's initial configuration can be made without the need to re-enter or otherwise access the lumen.
2 0 Brief Description of the Drawings For a more complete understanding of the present invention and the advantages thereof, reference is now made to the following description taken in conjunction with the accompanying drawings in which:
FIGURE 1 is a side view of the remotely operable stmt of the present invention;
FIGURE 2 is a side view, partially in section, of the remotely operable stmt of the present invention within a body lumen including stenosis;
FIGURE 3 is a side view, partially in section, of the remotely operable stmt of the present invention having an initial configuration within a body lumen;
FIGURE 4 is a side view, partially in section, of the remotely operable stmt of the present invention within a body lumen, in a configuration different than its initial configuration; and FIGURE 5 is a block diagram of the remote activation system.
Detailed Description of the Preferred and Alternative Embodiments Refernng to FIGURE 1, there is shown a stmt 10 incorporating the features of the preferred embodiment of the present invention. The stmt 10 generally comprises a radially cylindrical or tubular main body portion 12 comprising a medical grade, relatively flexible but generally shape-retaining material. Preferred materials include Ni-Ti binary alloy ("nitinol"), Ni-Ti-X (X being V, Co, Cu, Fe) ternary alloy, Cu-Zn-A1 ternary alloy, 1 S and Cu-Al-Ni ternary alloy. Alternatively, the stmt can comprise a plastic that is preferably bioabsorbable, biodegradable, biocompatible, non-thrombogenic and sterilizable. The plastic stmt is preferably made singly or of a combination of polymers such as polyactide, polyglycolide, polyactide-co-glycolide polydioxanone, polyethylene, polyiminocarbonates, polycaprolactone, polyesters and like materials.
Polymeric stems 2 0 can be provided with relatively fluid impenetrable walls, or porous walls such as to allow drug delivery, as will be apparent to one of skill in the art.
Located along the longitudinal length of the main body portion 12 are one or more actuators 14. The actuators) 14 is drivingly associated with one or more expansion/contraction elements 16 in a manner known in the art, such that the stmt is 2 5 expanded/contracted in response to one or more signals or movements from the one or more actuators) which itself is activated in response to one or more signals or other external (outside the lumen) activation processes from an external control source. In a preferred embodiment, a plurality of expansion/contraction elements 16 define bands around the main body 12 that are positioned external to the main body 12. In either embodiment, the one or more actuators) 14 are drivingly engaged with one or more of the the expansion/contraction elements) 16 in a manner known in the art, such as for example, worm gears or other transrotational transfer means. In response to the actuators) the expansion/contraction elements) 14 exert more or less pressure on the main body portion 12 of the stmt 10, causing the radial dimension of the main body portion 12 of the stmt 10 l0 to increase or decrease. The actuators) 14 that drive the expansion/contraction elements 16 are preferably micro-motors of a type generally known in the art, drivingly coupled, engaged or otherwise associated therewith. For example, Mussivand, et al.
(ASAIO
Journal 41:M253-258, 1995), describe the production of a transcutaneous air-core transformer for use with an implantable ventricular assist device, whereby diaphragm movement of the device is controlled via infrared communications between an external and internal coils. Furthermore, as discussed in U.S. Patent 5,92,037, planar micro-motors and electrically-driven actuators with minimum widths and heights of 20 micrometers or less can be fabricated through the use of well known techniques referred to as microfabrication of miniature devices ("MEMS"), and using well known materials.
2 0 Referring to FIGURE 5, the micro-motor will typically be responsive to an externally generated signal 24, for example an electromagnetic, IR or RF signal, produced by a remote activation system 26, causing actuation of actuator which in turn actuates or drives the expansion/contraction elements 16. Although a micro-motor coupled to an expansion/contraction element is disclosed herein, it is noted that any appropriate actuator 2 5 may be used, to control the movement of the expansion/contraction elements 16, if desired.
It will be obvious to one of ordinary skill in the art that the expansion/contraction elements 16 and the actuators) association/coupling can comprise any of the well known devices for translating input energy from the actuators) into radial pressure or other useful motion, such as disclosed in U.S. 5,92,037 and in Mussivand, et al.
The main body portion 12 of the stmt 10 is generally hollow in nature and is especially flexible along its longitudinal length. In a preferred embodiment of the instant invention, the stmt 10 is manufactured and sized such that the stmt 10 has its largest radial dimension in its relaxed state (i.e., when none of the expansion/contraction elements 16 are exerting radial pressure on the stmt 10). In this embodiment, the expansion/contraction l0 elements 16 apply pressure on the exterior of the main body portion 12 of the stmt 10 in respones to activation of the actuators drivingly associated therewith to decrease the radial dimension of the stmt 10.
In a further embodiment of the instant invention the stmt 10 is manufactured and sized such that such that in a completely relaxed state the stmt 10 has its smallest radial dimension. In this embodiment, the expansion/contraction elements) 16 applies pressure from inside the main body portion 12 of the stmt 10 in response to activation of the actuators) drivingly associated therewith to increase the radial dimension of the stent 10.
The actuators) 14 is controlled remotely via any suitable remote activation and control system, such as electromagnetic or RF energy, infrared and other suitable remote 2 0 activation and control systems known in the art. By remotely, applicant means the actuators) are actuated or activated in response to the activation system or signals in a manner such that the actuator and activation system/signal generator need not be in direct physical or intimate contact. Preferably, the activation system/signal generator is located external to the body cavity into which the stmt is implanted. For example, Mossivand, et 2 5 al. describe an infrared (IR) remote communication system for use with an implantable ventricular assist device. A digital data stream is input into the system using standard transistor transistor logic (TTL) signal levels of 0-5 V. The digital signal is converted into a sinusoidal signal, which is fed into an IR transmitter driver, which converts the electrical signal into a modulating IR light signal directed towards IR receivers on the other side of the skin and tissue barrier. An IR receiver inside the body picks up this IR
light signal and converts it back into a sinusoidal data stream, which is then utilized by the ventricular assist device. Similarly, methods for radio frequency transmission of energy into the body via remote means have been described, (Schuder, et al. IEEE Trans. Biomed.
Eng.
18:265-273, 1971; Mussivand et al.). It is contemplated that persons skilled in the art can use and adapt these known techniques to design a remote control device to remotely activate the actuators) in the stmt to cause radial expansion or compression thereof.
As illustrated in FIGURES 2-4, the stmt 10 of the present invention is prepared for insertion into a body lumen 18 requiring physical radial support by adjusting the size of the main body 12 of the stmt 10. The body lumen 18 illustrated includes an area of stenosis 20 requiring treatment. In the preferred embodiment, the stmt 10 is prepared for insertion into the body lumen 18 by actuating the expansion/contraction elements 16 via the actuators 14; so as to apply radial pressure to the main body portion 12 associated therewith, thus reducing the radial dimension of the stmt. This reduction is carried out until the longitudinal length of the stmt 10 is small enough in radial dimension to allow 2 0 the stmt 10 to pass through the path of the body lumen 18 and be positioned.
In the second embodiment, in which the stmt 10 is manufactured and sized to have its smallest radial dimension when in a completely relaxed state, the natural state of the stent 10 exhibits the smallest radial dimension in size and thus no actuation of the expansion/contraction elements 16 by the actuators) is required.
The stmt 10 is guided into the proper position within the body lumen 18 via a guidewire 22 or like device such as described in U.S. Patent No. 4,754,752, or as known in the art. Although a guidewire device is disclosed herein, it is noted that the stent 10 can be guided into proper position within a body lumen 18 using any appropriate device, as for example, a catheter system, also described in U.S. Patent No. 4,754,752.
Now referring to FIGURE 3, once the stmt 10 is in place within the body lumen 18, the guidewire 22 is removed and the main body portion 12 is expanded to provide radial support to the stenotic area 22 of the body lumen 18. This is accomplished via the remote transmitter sending an RF electromagnetic signal, or other suitable signal, to the actuator 14, which responsively activates the expansion/contraction element 16 to adjust the radial force applied to the main body portion 12 of the stmt 10. In the preferred embodiment, as such radial force decreases, the generally shape-retaining nature of the material of the stmt 10 naturally expands to increase the radial dimension of the main body portion 12 of the stmt 10. Depending upon the needs of the patient, the condition of the body lumen 18 requiring support, and like factors, the main body portion 12 of the stmt 10 is expanded slightly or, alternatively, to its full radial dimension to provide the needed radial support. As can be seen in FIGURE 4, the stmt 10 is configured to provide maximum radial support to the body lumen 18. Once the stmt 10 is in the initial configuration (FIGURE 3) the insertion procedure is complete. Subsequently, to avoid 2 0 discomfort to, injury or rupture of the body lumen 18, the stmt 10 can be expanded incrementally over a prolonged period of time via the remote activation system, while providing the maximum radial support to the body lumen 18. Additionally, adjustments to the configuration of the stmt 10 can be made without re-entering or otherwise invasively accessing the body lumen 18. This feature of the stmt 10 allows, for example, a physician 2 5 or other medical personnel to expand or contract the main body portion 12 of the stmt 10 in the event the stmt 10 becomes crimped or otherwise adversely affected through activity or changing medical condition without the need for invasive surgical procedures.
The second embodiment described herein operates identically to the preferred embodiment, except that the expansion/contraction elements 16 of the stmt 10 of the second embodiment apply radially outward forces from within the main body portion 12 of the stmt 10 to increase the stmt's radial dimension.
Although preferred embodiments of the invention have been illustrated in the accompanying drawings and described in the foregoing Detailed Description, it will be understood that the invention is not limited to the embodiments disclosed, but is capable of modification without departing from the spirit of the invention.
The stmt of the present invention comprises a radially cylindrical body portion.
Located at one or more locations along its longitudinal length is one or more actuators drivingly associated with one or more expansion/contraction elements that serve to expand 2 5 or contract the stmt's diameter. In a preferred embodiment, the stmt is manufactured and sized such that in a completely relaxed state (i.e., when no radial pressure is exerted on the main body of the stmt) the stmt is at its largest radial dimension. When the one or more expansion/contraction elements are activated by means of one or more signals to the one or more actuators, the main body is reduced/increased in radial dimension in direct proportion to the amount of pressure exerted by the activation of the expansion/contraction elements.
In another embodiment of the present invention, the stmt is manufactured and sized such that in a completely relaxed state the stmt exhibits its smallest radial dimension.
In this embodiment the one or more expansion/contraction elements apply radial pressure from within the main portion of the stmt. When the expansion/contraction elements are 1 o actuated by means of one or more signals received by the one or more actuators, the main body is increased/reduced in radial dimension in direct proportion to the amount of pressure exerted by the activation of the expansion/contraction elements.
In both of the above-identified embodiments, the one or more expansion/contraction elements are remotely operable by the activation of one or more actuators by any one of a number of remote means such as electromagnetic radiation, including radio frequency (RF) energy and infrared remote activation and control systems.
In use, the remotely operable stmt of the present invention is prepared for insertion into the body lumen requiring physical radial support by adjusting the size of the main body of the stmt. If the embodiment includes the stmt manufactured and sized to have its 2 0 largest radial dimension when in a completely relaxed state, this is accomplished by actuating the actuators) which in turn drive, or activate the expansion/contraction elements to apply radial pressure to the external surface of the main body of the stmt, thus reducing the radial dimension of the stmt. This reduction is continued until the radial dimension of the stmt is small enough to allow the stent to pass through the path of the 2 5 body lumen and to be positioned appropriately, at which point the activation signals are terminated. In the second embodiment, when the stmt is manufactured and sized to have its smallest radial dimension when in a completely relaxed state, the natural state of the stmt is appropriate for insertion and thus actuation of the one or more actuators drivingly associated with the expansion/contraction is not required.
Once positioned within the body lumen, the main body of the stmt is expanded or contracted by transmitting the activation signals) to the actuators) which control the expansion/contraction elements to remove or add radial pressure and thereby to provide more or less radial support. The main body of the stmt is expanded to its initial configuration (i.e., either slightly expanded, or alternatively, expanded to its full radial dimension), depending upon the needs of the patient, the condition of the body lumen requiring support and other factors.
Once the remotely operable stent of the present invention is in the initial configuration, the insertion procedure is completed. Subsequently, unlimited adjustments to the stmt's initial configuration can be accomplished via remote means, without additional invasive means. Accordingly, the stmt can be incrementally expanded over a prolonged period of time to reduce the chance of injury or rupture to the lumen to be supported. Additionally, as the activity and/or condition of the patient warrants, adjustments to the stent's initial configuration can be made without the need to re-enter or otherwise access the lumen.
2 0 Brief Description of the Drawings For a more complete understanding of the present invention and the advantages thereof, reference is now made to the following description taken in conjunction with the accompanying drawings in which:
FIGURE 1 is a side view of the remotely operable stmt of the present invention;
FIGURE 2 is a side view, partially in section, of the remotely operable stmt of the present invention within a body lumen including stenosis;
FIGURE 3 is a side view, partially in section, of the remotely operable stmt of the present invention having an initial configuration within a body lumen;
FIGURE 4 is a side view, partially in section, of the remotely operable stmt of the present invention within a body lumen, in a configuration different than its initial configuration; and FIGURE 5 is a block diagram of the remote activation system.
Detailed Description of the Preferred and Alternative Embodiments Refernng to FIGURE 1, there is shown a stmt 10 incorporating the features of the preferred embodiment of the present invention. The stmt 10 generally comprises a radially cylindrical or tubular main body portion 12 comprising a medical grade, relatively flexible but generally shape-retaining material. Preferred materials include Ni-Ti binary alloy ("nitinol"), Ni-Ti-X (X being V, Co, Cu, Fe) ternary alloy, Cu-Zn-A1 ternary alloy, 1 S and Cu-Al-Ni ternary alloy. Alternatively, the stmt can comprise a plastic that is preferably bioabsorbable, biodegradable, biocompatible, non-thrombogenic and sterilizable. The plastic stmt is preferably made singly or of a combination of polymers such as polyactide, polyglycolide, polyactide-co-glycolide polydioxanone, polyethylene, polyiminocarbonates, polycaprolactone, polyesters and like materials.
Polymeric stems 2 0 can be provided with relatively fluid impenetrable walls, or porous walls such as to allow drug delivery, as will be apparent to one of skill in the art.
Located along the longitudinal length of the main body portion 12 are one or more actuators 14. The actuators) 14 is drivingly associated with one or more expansion/contraction elements 16 in a manner known in the art, such that the stmt is 2 5 expanded/contracted in response to one or more signals or movements from the one or more actuators) which itself is activated in response to one or more signals or other external (outside the lumen) activation processes from an external control source. In a preferred embodiment, a plurality of expansion/contraction elements 16 define bands around the main body 12 that are positioned external to the main body 12. In either embodiment, the one or more actuators) 14 are drivingly engaged with one or more of the the expansion/contraction elements) 16 in a manner known in the art, such as for example, worm gears or other transrotational transfer means. In response to the actuators) the expansion/contraction elements) 14 exert more or less pressure on the main body portion 12 of the stmt 10, causing the radial dimension of the main body portion 12 of the stmt 10 l0 to increase or decrease. The actuators) 14 that drive the expansion/contraction elements 16 are preferably micro-motors of a type generally known in the art, drivingly coupled, engaged or otherwise associated therewith. For example, Mussivand, et al.
(ASAIO
Journal 41:M253-258, 1995), describe the production of a transcutaneous air-core transformer for use with an implantable ventricular assist device, whereby diaphragm movement of the device is controlled via infrared communications between an external and internal coils. Furthermore, as discussed in U.S. Patent 5,92,037, planar micro-motors and electrically-driven actuators with minimum widths and heights of 20 micrometers or less can be fabricated through the use of well known techniques referred to as microfabrication of miniature devices ("MEMS"), and using well known materials.
2 0 Referring to FIGURE 5, the micro-motor will typically be responsive to an externally generated signal 24, for example an electromagnetic, IR or RF signal, produced by a remote activation system 26, causing actuation of actuator which in turn actuates or drives the expansion/contraction elements 16. Although a micro-motor coupled to an expansion/contraction element is disclosed herein, it is noted that any appropriate actuator 2 5 may be used, to control the movement of the expansion/contraction elements 16, if desired.
It will be obvious to one of ordinary skill in the art that the expansion/contraction elements 16 and the actuators) association/coupling can comprise any of the well known devices for translating input energy from the actuators) into radial pressure or other useful motion, such as disclosed in U.S. 5,92,037 and in Mussivand, et al.
The main body portion 12 of the stmt 10 is generally hollow in nature and is especially flexible along its longitudinal length. In a preferred embodiment of the instant invention, the stmt 10 is manufactured and sized such that the stmt 10 has its largest radial dimension in its relaxed state (i.e., when none of the expansion/contraction elements 16 are exerting radial pressure on the stmt 10). In this embodiment, the expansion/contraction l0 elements 16 apply pressure on the exterior of the main body portion 12 of the stmt 10 in respones to activation of the actuators drivingly associated therewith to decrease the radial dimension of the stmt 10.
In a further embodiment of the instant invention the stmt 10 is manufactured and sized such that such that in a completely relaxed state the stmt 10 has its smallest radial dimension. In this embodiment, the expansion/contraction elements) 16 applies pressure from inside the main body portion 12 of the stmt 10 in response to activation of the actuators) drivingly associated therewith to increase the radial dimension of the stent 10.
The actuators) 14 is controlled remotely via any suitable remote activation and control system, such as electromagnetic or RF energy, infrared and other suitable remote 2 0 activation and control systems known in the art. By remotely, applicant means the actuators) are actuated or activated in response to the activation system or signals in a manner such that the actuator and activation system/signal generator need not be in direct physical or intimate contact. Preferably, the activation system/signal generator is located external to the body cavity into which the stmt is implanted. For example, Mossivand, et 2 5 al. describe an infrared (IR) remote communication system for use with an implantable ventricular assist device. A digital data stream is input into the system using standard transistor transistor logic (TTL) signal levels of 0-5 V. The digital signal is converted into a sinusoidal signal, which is fed into an IR transmitter driver, which converts the electrical signal into a modulating IR light signal directed towards IR receivers on the other side of the skin and tissue barrier. An IR receiver inside the body picks up this IR
light signal and converts it back into a sinusoidal data stream, which is then utilized by the ventricular assist device. Similarly, methods for radio frequency transmission of energy into the body via remote means have been described, (Schuder, et al. IEEE Trans. Biomed.
Eng.
18:265-273, 1971; Mussivand et al.). It is contemplated that persons skilled in the art can use and adapt these known techniques to design a remote control device to remotely activate the actuators) in the stmt to cause radial expansion or compression thereof.
As illustrated in FIGURES 2-4, the stmt 10 of the present invention is prepared for insertion into a body lumen 18 requiring physical radial support by adjusting the size of the main body 12 of the stmt 10. The body lumen 18 illustrated includes an area of stenosis 20 requiring treatment. In the preferred embodiment, the stmt 10 is prepared for insertion into the body lumen 18 by actuating the expansion/contraction elements 16 via the actuators 14; so as to apply radial pressure to the main body portion 12 associated therewith, thus reducing the radial dimension of the stmt. This reduction is carried out until the longitudinal length of the stmt 10 is small enough in radial dimension to allow 2 0 the stmt 10 to pass through the path of the body lumen 18 and be positioned.
In the second embodiment, in which the stmt 10 is manufactured and sized to have its smallest radial dimension when in a completely relaxed state, the natural state of the stent 10 exhibits the smallest radial dimension in size and thus no actuation of the expansion/contraction elements 16 by the actuators) is required.
The stmt 10 is guided into the proper position within the body lumen 18 via a guidewire 22 or like device such as described in U.S. Patent No. 4,754,752, or as known in the art. Although a guidewire device is disclosed herein, it is noted that the stent 10 can be guided into proper position within a body lumen 18 using any appropriate device, as for example, a catheter system, also described in U.S. Patent No. 4,754,752.
Now referring to FIGURE 3, once the stmt 10 is in place within the body lumen 18, the guidewire 22 is removed and the main body portion 12 is expanded to provide radial support to the stenotic area 22 of the body lumen 18. This is accomplished via the remote transmitter sending an RF electromagnetic signal, or other suitable signal, to the actuator 14, which responsively activates the expansion/contraction element 16 to adjust the radial force applied to the main body portion 12 of the stmt 10. In the preferred embodiment, as such radial force decreases, the generally shape-retaining nature of the material of the stmt 10 naturally expands to increase the radial dimension of the main body portion 12 of the stmt 10. Depending upon the needs of the patient, the condition of the body lumen 18 requiring support, and like factors, the main body portion 12 of the stmt 10 is expanded slightly or, alternatively, to its full radial dimension to provide the needed radial support. As can be seen in FIGURE 4, the stmt 10 is configured to provide maximum radial support to the body lumen 18. Once the stmt 10 is in the initial configuration (FIGURE 3) the insertion procedure is complete. Subsequently, to avoid 2 0 discomfort to, injury or rupture of the body lumen 18, the stmt 10 can be expanded incrementally over a prolonged period of time via the remote activation system, while providing the maximum radial support to the body lumen 18. Additionally, adjustments to the configuration of the stmt 10 can be made without re-entering or otherwise invasively accessing the body lumen 18. This feature of the stmt 10 allows, for example, a physician 2 5 or other medical personnel to expand or contract the main body portion 12 of the stmt 10 in the event the stmt 10 becomes crimped or otherwise adversely affected through activity or changing medical condition without the need for invasive surgical procedures.
The second embodiment described herein operates identically to the preferred embodiment, except that the expansion/contraction elements 16 of the stmt 10 of the second embodiment apply radially outward forces from within the main body portion 12 of the stmt 10 to increase the stmt's radial dimension.
Although preferred embodiments of the invention have been illustrated in the accompanying drawings and described in the foregoing Detailed Description, it will be understood that the invention is not limited to the embodiments disclosed, but is capable of modification without departing from the spirit of the invention.
Claims (5)
- I claim:
A stent remotely and non-invasively adjustable when the stent is implanted in a living animal comprising:
a tubular body portion defining a longitudinal length, a hollow interior and an exterior surface;
one or more expansion/contraction elements located along said longitudinal length of said body portion; and one or more actuators operatively associated with said one or more expansion/contraction elements, wherein said actuators are remotely responsive to an activation signal from a control source remote from said one or more actuators for operatively actuating said one or more expansion/contraction elements for increasing or decreasing the radial dimension of said body portion of said stent. - 2. A system for remotely controlling the radial dimension of a stent implanted in a living animal, comprising:
a stent remotely adjustable when the stent is implanted in a living animal comprising:
a tubular body portion defining a longitudinal length, a hollow interior and an exterior surface;
one or more expansion/contraction elements located along said longitudinal length of said body portion; and one or more actuators operatively associated with said one or more expansion/contraction elements; and a control source for transmitting an activation signal, said control source located remote from and external to said one or more actuators;
wherein said actuators are responsive to an activation signal from said remotely located control source; and whereby the expansion and contraction of said stent are remotely adjusted by means of said remotely located control source. - 3. The system of claim 2, wherein said control source comprises a source of electromagnetic radiation and means of transmission thereof.
- 4. The system of claim 2, wherein said source comprises an infrared source.
- 5. The system of claim 2, wherein said source comprises a radio-frequency energy source.
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/046,175 US5972029A (en) | 1997-05-13 | 1998-03-23 | Remotely operable stent |
EP99650069A EP1077049A1 (en) | 1998-03-23 | 1999-08-16 | Remotely operable stent |
JP22990699A JP3169943B2 (en) | 1998-03-23 | 1999-08-16 | Teleoperable stent |
CA002280416A CA2280416A1 (en) | 1998-03-23 | 1999-08-16 | Remotely operable stent |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/046,175 US5972029A (en) | 1997-05-13 | 1998-03-23 | Remotely operable stent |
EP99650069A EP1077049A1 (en) | 1998-03-23 | 1999-08-16 | Remotely operable stent |
JP22990699A JP3169943B2 (en) | 1998-03-23 | 1999-08-16 | Teleoperable stent |
CA002280416A CA2280416A1 (en) | 1998-03-23 | 1999-08-16 | Remotely operable stent |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2280416A1 true CA2280416A1 (en) | 2001-02-16 |
Family
ID=27427537
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002280416A Abandoned CA2280416A1 (en) | 1997-05-13 | 1999-08-16 | Remotely operable stent |
Country Status (4)
Country | Link |
---|---|
US (1) | US5972029A (en) |
EP (1) | EP1077049A1 (en) |
JP (1) | JP3169943B2 (en) |
CA (1) | CA2280416A1 (en) |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8790391B2 (en) * | 1997-04-18 | 2014-07-29 | Cordis Corporation | Methods and devices for delivering therapeutic agents to target vessels |
US6350277B1 (en) | 1999-01-15 | 2002-02-26 | Scimed Life Systems, Inc. | Stents with temporary retaining bands |
US6896690B1 (en) | 2000-01-27 | 2005-05-24 | Viacor, Inc. | Cardiac valve procedure methods and devices |
US6170488B1 (en) * | 1999-03-24 | 2001-01-09 | The B. F. Goodrich Company | Acoustic-based remotely interrogated diagnostic implant device and system |
US6206835B1 (en) | 1999-03-24 | 2001-03-27 | The B. F. Goodrich Company | Remotely interrogated diagnostic implant device with electrically passive sensor |
US6308715B1 (en) | 1999-03-24 | 2001-10-30 | Pmd Holdings Corp. | Ultrasonic detection of restenosis in stents |
US6317615B1 (en) | 1999-04-19 | 2001-11-13 | Cardiac Pacemakers, Inc. | Method and system for reducing arterial restenosis in the presence of an intravascular stent |
US7749245B2 (en) * | 2000-01-27 | 2010-07-06 | Medtronic, Inc. | Cardiac valve procedure methods and devices |
US9522217B2 (en) | 2000-03-15 | 2016-12-20 | Orbusneich Medical, Inc. | Medical device with coating for capturing genetically-altered cells and methods for using same |
US8088060B2 (en) | 2000-03-15 | 2012-01-03 | Orbusneich Medical, Inc. | Progenitor endothelial cell capturing with a drug eluting implantable medical device |
US6764505B1 (en) | 2001-04-12 | 2004-07-20 | Advanced Cardiovascular Systems, Inc. | Variable surface area stent |
US20040225326A1 (en) * | 2001-05-07 | 2004-11-11 | Weiner Mike L. | Apparatus for the detection of restenosis |
US7862495B2 (en) | 2001-05-31 | 2011-01-04 | Advanced Cardiovascular Systems, Inc. | Radiation or drug delivery source with activity gradient to minimize edge effects |
US6626940B2 (en) | 2001-06-15 | 2003-09-30 | Scimed Life Systems, Inc. | Medical device activation system |
US7493162B2 (en) | 2001-06-15 | 2009-02-17 | Cardiac Pacemakers, Inc. | Pulmonary vein stent for treating atrial fibrillation |
US6656216B1 (en) | 2001-06-29 | 2003-12-02 | Advanced Cardiovascular Systems, Inc. | Composite stent with regioselective material |
US7097658B2 (en) * | 2001-08-22 | 2006-08-29 | Hasan Semih Oktay | Flexible MEMS actuated controlled expansion stent |
US7223282B1 (en) | 2001-09-27 | 2007-05-29 | Advanced Cardiovascular Systems, Inc. | Remote activation of an implantable device |
US20030065386A1 (en) * | 2001-09-28 | 2003-04-03 | Weadock Kevin Shaun | Radially expandable endoprosthesis device with two-stage deployment |
US7236821B2 (en) * | 2002-02-19 | 2007-06-26 | Cardiac Pacemakers, Inc. | Chronically-implanted device for sensing and therapy |
US7169178B1 (en) | 2002-11-12 | 2007-01-30 | Advanced Cardiovascular Systems, Inc. | Stent with drug coating |
WO2005032413A2 (en) * | 2003-09-30 | 2005-04-14 | Alveolus Inc. | Active stent |
US7198675B2 (en) | 2003-09-30 | 2007-04-03 | Advanced Cardiovascular Systems | Stent mandrel fixture and method for selectively coating surfaces of a stent |
US8915957B2 (en) * | 2004-03-11 | 2014-12-23 | Alcatel Lucent | Drug delivery stent |
US7567841B2 (en) | 2004-08-20 | 2009-07-28 | Cardiac Pacemakers, Inc. | Method and apparatus for delivering combined electrical and drug therapies |
US8750983B2 (en) | 2004-09-20 | 2014-06-10 | P Tech, Llc | Therapeutic system |
US7887579B2 (en) | 2004-09-29 | 2011-02-15 | Merit Medical Systems, Inc. | Active stent |
US7499748B2 (en) | 2005-04-11 | 2009-03-03 | Cardiac Pacemakers, Inc. | Transvascular neural stimulation device |
US7617003B2 (en) | 2005-05-16 | 2009-11-10 | Cardiac Pacemakers, Inc. | System for selective activation of a nerve trunk using a transvascular reshaping lead |
WO2007029252A2 (en) * | 2005-09-06 | 2007-03-15 | Vital Valve (Israel) Ltd. | Method and device for treatment of congestive heart failure and valve dysfunction |
US8211088B2 (en) | 2005-10-14 | 2012-07-03 | Boston Scientific Scimed, Inc. | Catheter with controlled lumen recovery |
US7616990B2 (en) | 2005-10-24 | 2009-11-10 | Cardiac Pacemakers, Inc. | Implantable and rechargeable neural stimulator |
US7867547B2 (en) | 2005-12-19 | 2011-01-11 | Advanced Cardiovascular Systems, Inc. | Selectively coating luminal surfaces of stents |
US8069814B2 (en) | 2006-05-04 | 2011-12-06 | Advanced Cardiovascular Systems, Inc. | Stent support devices |
US8603530B2 (en) | 2006-06-14 | 2013-12-10 | Abbott Cardiovascular Systems Inc. | Nanoshell therapy |
US8048448B2 (en) | 2006-06-15 | 2011-11-01 | Abbott Cardiovascular Systems Inc. | Nanoshells for drug delivery |
US8017237B2 (en) | 2006-06-23 | 2011-09-13 | Abbott Cardiovascular Systems, Inc. | Nanoshells on polymers |
US9585743B2 (en) | 2006-07-31 | 2017-03-07 | Edwards Lifesciences Cardiaq Llc | Surgical implant devices and methods for their manufacture and use |
US9408607B2 (en) | 2009-07-02 | 2016-08-09 | Edwards Lifesciences Cardiaq Llc | Surgical implant devices and methods for their manufacture and use |
WO2008016578A2 (en) * | 2006-07-31 | 2008-02-07 | Cartledge Richard G | Sealable endovascular implants and methods for their use |
WO2008028037A2 (en) * | 2006-08-30 | 2008-03-06 | Andrew Young | Distender device and method for treatment of obesity and metabolic and other diseases |
US8048441B2 (en) | 2007-06-25 | 2011-11-01 | Abbott Cardiovascular Systems, Inc. | Nanobead releasing medical devices |
US9566178B2 (en) | 2010-06-24 | 2017-02-14 | Edwards Lifesciences Cardiaq Llc | Actively controllable stent, stent graft, heart valve and method of controlling same |
US9814611B2 (en) | 2007-07-31 | 2017-11-14 | Edwards Lifesciences Cardiaq Llc | Actively controllable stent, stent graft, heart valve and method of controlling same |
US20130211489A1 (en) * | 2010-02-10 | 2013-08-15 | Apertomed L.L.C. | Methods, Systems and Devices for Treatment of Cerebrospinal Venous Insufficiency and Multiple Sclerosis |
US20120130468A1 (en) | 2010-07-27 | 2012-05-24 | Fred Khosravi | Methods and apparatus for treating neurovascular venous outflow obstruction |
US8558489B2 (en) | 2010-12-02 | 2013-10-15 | Raytheon Company | Micro motor |
US9827093B2 (en) | 2011-10-21 | 2017-11-28 | Edwards Lifesciences Cardiaq Llc | Actively controllable stent, stent graft, heart valve and method of controlling same |
US10603195B1 (en) | 2015-05-20 | 2020-03-31 | Paul Sherburne | Radial expansion and contraction features of medical devices |
US11291568B2 (en) | 2017-08-29 | 2022-04-05 | C.R. Bard, Inc. | Reconfigurable stent, and systems and methods for use thereof |
WO2023046455A1 (en) * | 2021-09-22 | 2023-03-30 | Koninklijke Philips N.V. | Imaging based reperfusion therapy monitoring devices, systems, and methods |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4754752A (en) * | 1986-07-28 | 1988-07-05 | Robert Ginsburg | Vascular catheter |
US5190540A (en) * | 1990-06-08 | 1993-03-02 | Cardiovascular & Interventional Research Consultants, Inc. | Thermal balloon angioplasty |
US5412265A (en) * | 1993-04-05 | 1995-05-02 | Ford Motor Company | Planar micro-motor and method of fabrication |
US5716410A (en) * | 1993-04-30 | 1998-02-10 | Scimed Life Systems, Inc. | Temporary stent and method of use |
IL105828A (en) * | 1993-05-28 | 1999-06-20 | Medinol Ltd | Medical stent |
US5406158A (en) * | 1993-07-23 | 1995-04-11 | Eaton Corporation | Miniature synchronous motor |
WO1995007109A1 (en) * | 1993-09-10 | 1995-03-16 | Ottawa Heart Institute Research Corporation | Electrohydraulic ventricular assist device |
US5476505A (en) * | 1993-11-18 | 1995-12-19 | Advanced Cardiovascular Systems, Inc. | Coiled stent and delivery system |
US5676685A (en) * | 1995-06-22 | 1997-10-14 | Razavi; Ali | Temporary stent |
-
1998
- 1998-03-23 US US09/046,175 patent/US5972029A/en not_active Expired - Fee Related
-
1999
- 1999-08-16 CA CA002280416A patent/CA2280416A1/en not_active Abandoned
- 1999-08-16 EP EP99650069A patent/EP1077049A1/en not_active Withdrawn
- 1999-08-16 JP JP22990699A patent/JP3169943B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP2001046511A (en) | 2001-02-20 |
JP3169943B2 (en) | 2001-05-28 |
US5972029A (en) | 1999-10-26 |
EP1077049A1 (en) | 2001-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5972029A (en) | Remotely operable stent | |
US5221261A (en) | Radially expandable fixation member | |
US5071407A (en) | Radially expandable fixation member | |
US9526641B2 (en) | Self constraining radially expandable medical devices | |
US5649978A (en) | Temporary inflatable intravascular prosthesis | |
JP2940859B2 (en) | Shape memory lock mechanism for intravascular stent | |
US6319275B1 (en) | Endolumenal prosthesis delivery assembly and method of use | |
EP0820259B1 (en) | Rolling membrane stent delivery device | |
AU726548B2 (en) | Contraceptive system and method of use | |
AU2005253930B2 (en) | Interfacial stent and method of maintaining patency of surgical fenestrations | |
US20090171448A1 (en) | Implantable device with miniature rotating portion for energy harvesting | |
US20120035701A1 (en) | Stent strut appositioner | |
US20230225736A1 (en) | Vascular Flow and Pressure Modulator | |
JP2008502441A (en) | Stent delivery system | |
JP2007513743A (en) | Removable stent / graft | |
WO2011011787A2 (en) | Interfacial stent and method of maintaining patency of surgical fenestrations | |
JPH03155869A (en) | Stent and stent introducing catheter | |
WO2011084342A1 (en) | Delivery system with retractable proximal end | |
EP0984741B1 (en) | A modular prosthetic conduit | |
WO2007112064A2 (en) | Conformable vascular prosthesis delivery system | |
MXPA99007537A (en) | Remotely operable insertion device | |
KR20010017846A (en) | Remotely Operable Stent | |
EP1493401B1 (en) | Hybrid stent apparatus | |
CN211271434U (en) | Prevent displacement detachable ureter metal tectorial membrane support | |
CA1274740A (en) | Intravascular stent and percutaneous catheter system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Dead |